New Delhi [India], September 9 (ANI): The Drugs Regulator General of India (DCGI) has issued a show-cause notice to pharma giant Serum Institute of India (SII) asking for an explanation as to why the ongoing clinical trial of Covishield vaccine candidate has not been suspended till doubts
New Delhi [India], September 4 (ANI): Russia is in close dialogue with the Indian government and the leading drug manufactures of India regarding the localization of production of Sputnik V vaccine in India, said Kirill Dmitriev, CEO of the Russian Direct Investment Fund (RDIF) on Friday.
New Delhi [India], Aug 4 (ANI): In a first in India, the technical expert committee at the Union Health Ministry created Prescribed Minimum Essential Specifications for "Make in India ventilators" to be used in COVID-19 ICU, a senior health ministry official said on Tuesday.
New Delhi [India], July 24 (ANI): The All India Institute of Medical Sciences (AIIMS) on Friday administered the first dose of country's first indigenous vaccine candidate `Covaxin' to a 30-year-old man as part of efforts to combat COVID-19.
New Delhi [India], July 18 (ANI): The All India Institute of Medical Sciences (AIIMS) Ethics Committee on Saturday gave its approval for conducting the human clinical trial of the indigenously developed COVID-19 vaccine candidate Covaxin.
New Delhi, [India], July 18 (ANI): The Union Health Ministry has directed the government of Bihar, Odisha, West Bengal and Assam to take necessary steps to suppress COVID-19 transmission as well as to keep case fatality rate below 1 per cent.
New Delhi [India], July 15 (ANI): Indian pharmaceutical giant Zydus Cadila has initiated the phase 1, 2 clinical trial to evaluate the safety and immunogenicity of coronavirus vaccine candidate by intradermal (injection) route in 1,048 subjects after the pharma company got approval from D
New Delhi [India], July 14 (ANI): The Union Health Ministry on Tuesday informed that the daily growth rate of newer coronavirus cases is declining each day. Till July 12, the Central government has recorded daily the growth rate for newer cases at 3.24 per cent.
New Delhi [India], July 11 (ANI): The Drug Controller General of India (DCGI) granted its permission to Itolizumab injection for the restricted emergency use on COVID-19 patients with moderate to severe Acute Respiratory Distress Syndrome (ARDS) due to virus.
New Delhi [India], July 3 (ANI): The Drug Controller General of India (DCGI) on Thursday granted permission to pharma giant Zydus Cadila to conduct phase I and phase II human clinical trials for COVID -19 vaccine, a top government official told ANI.
New Delhi [India], June 22 (ANI): The National Centre for Disease Control (NCDC) is set to conduct a sero-surveillance study in all 11 districts of Delhi focusing on as many as 20,000 households on a random basis including individuals below 18 years of age. The survey is expected to start
New Delhi [India], June 13 (ANI): The Union Health Ministry issued a fresh clinical management protocol for COVID-19 patients on Saturday. As per the latest protocol, the health ministry has described the use of investigational therapies--Remdesivir, Convalescent plasma, Tocilizumab, and